SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

HIKAL

BSE: 524735 30 Sep 2025
Healthcare
₹ 252
Hikal Ltd. specializes in Pharmaceuticals within the Healthcare sector.

HIKAL - Share Price & Details

Market Cap
₹3,145
High /Low
465.0 / 245.0
Stock P/E
49.7
Book Value
₹102.0
Dividend Yield
0.55
ROCE
9.85
ROE
₹7.38
Face Value
2.0
PEG Ratio
-2.86
EVEBITDA
₹12.9
Debt
765
CMP / FCF
67.4
Debt to equity
₹0.61
NP Ann
90.8
High price all time
742.0
Piotroski score
₹7.0
Graham Number
109.0
No. Eq. Shares
12.3
Net CF
₹0.30
Net profit
63.3
Price to book value
2.49
Interest Coverage
₹2.19
Low price all time
15.8
Industry PE
33.0
Reserves
₹1,238
Free Cash Flow
₹144

Broker Recommendations

No broker recommendations available

We couldn’t find any recent recommendations for this company (matched by symbol or BSE code). Please check back later.


Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.0984.8
Triochem Products Ltd.,NANANANA0
HIKAL LTD.3814.0-227.03804.0-1.843,14549.7
IOL CHEMICALS & PHARMACEUTICAL5590.6339.65516.91.16304929.0
PANACEA BIOTEC LTD.1172.0-67.01122.5-1.092762

Peer Comparison Chart


About HIKAL

Hikal Ltd., with Security Code 524735, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Order Book


Latest News

अब क्या हुआ है Kalyani Investment और Hikal में Amit Kalyani की री-अपॉइंटमेंट पर, जानिए सबकुछ

(23 Sep 2025)
Hikal Ltd. में Amit Kalyani की Non-Executive Non-Independent Director के तौर पर दोबारा नियुक्ति को लेकर खींचतान तेज हो गई है. Institutional Investor Advisory...
Read more →

Hikal AGM to take up Amit Kalyani reappointment, as proxy firms take sides in family feud

(23 Sep 2025)
A simmering ownership dispute between Hikal Ltd's co-promoter families, the Kalyanis and the Hiremaths, has now become a test of boardroom...
Read more →

Kalyani Investment rebuts IIAS voting advice on Amit Kalyani at Hikal

(23 Sep 2025)
Kalyani Investment has challenged IIAS's negative advice on Amit Kalyani's reappointment to Hikal's board, stressing his non-involvement in...
Read more →

Hikal Limited's (NSE:HIKAL) CEO Might Not Expect Shareholders To Be So Generous This Year

(17 Sep 2025)
Key Insights Hikal to hold its Annual General Meeting on 23rd of September Salary of ₹49.4m is part of CEO Sameer...
Read more →

Omission of GST Rules 89(4B) & 96(10) Without Saving Clause: Bombay HC’s Ruling in Hikal Ltd. Case

(13 Sep 2025)
The pending show cause notices, orders passed thereafter, or orders under challenge but not final, could not be saved under Section 6,...
Read more →

Just Three Days Till Hikal Limited (NSE:HIKAL) Will Be Trading Ex-Dividend

(29 Aug 2025)
Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Hikal Limited...
Read more →